This inventor holds 2 USPTO granted patents and 1 published patent application. Top assignee: Alza Corporation. Active years: 1992-1993.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Stanford, CA (US) (1992)
- Menlo Park, CA (US) (1993)
Company Filing History:
Years Active: 1992-1993
Title: The Innovations of Stephen C DeRosa
Introduction
Stephen C DeRosa is a notable inventor based in Stanford, CA. He has made significant contributions to the field of cardiovascular therapy, holding 2 patents that focus on innovative dosage forms for administering nicardipine, a calcium antagonist.
Latest Patents
His latest patents include a dosage form comprising nicardipine and its pharmaceutically acceptable salts for administering to patients in need of cardiovascular therapy. Another patent details a similar dosage form specifically designed for the administration of calcium antagonist nicardipine.
Career Highlights
Stephen C DeRosa is associated with Alza Corporation, where he has been instrumental in developing therapeutic solutions. His work has had a profound impact on the treatment of cardiovascular conditions.
Collaborations
Some of his notable coworkers include Joseph C Deters and David R Swanson, who have collaborated with him on various projects.
Conclusion
Stephen C DeRosa's contributions to cardiovascular therapy through his innovative patents highlight his role as a significant figure in the field of medical inventions. His work continues to influence the development of effective treatment options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile